George Medicines initiates two Phase III trials of triple combination candidate to treat hypertension

NEXT STORY
Global Healthcare-Acquired Infection: Devices, Pharmaceuticals, and Environmental Products Market Report to 2026 – Featuring Gilead Sciences, Merck and Novartis Among Others
PREV STORY
Sequana Medical Announces Positive Results From Second Interim Analysis of North American Pivotal alfapump® Study (POSEIDON)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Melinta Therapeutics Announces U.S. FDA Approval of Supplemental New Drug Application for BAXDELA® (delafloxacin) for the Treatment of Community-Acquired Bacterial Pneumonia (CABP)

author_avatar
NASDAQ Market News

Allena Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update

-- Global Phase 3 URIROX-1™ Trial Ongoing; Expect to Initiate Second Phase 3 Study, ...

author_avatar
NASDAQ Market News

GUESS & CO. CORPORATION PROVIDES PLAN TO RE-OPEN COUNTRY

author_avatar
NASDAQ Market News